Sirolimus does not potentiate indices of chronic cyclosporin nephrotoxicity

Transplant Proc. 2001 Feb-Mar;33(1-2):1061-3. doi: 10.1016/s0041-1345(00)02416-7.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase III

MeSH terms

  • Chronic Disease
  • Cyclosporine / adverse effects*
  • Drug Synergism
  • Female
  • Histocompatibility
  • Humans
  • Immunosuppressive Agents / pharmacology*
  • Kidney / drug effects*
  • Male
  • Middle Aged
  • Sirolimus / pharmacology*

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Sirolimus